Biochim Biophys Acta 2010, 1799:86–92.PubMed 13. Shirakawa H, Herrera JE, Bustin M, Postnikov Y: Targeting of high mobility group-14/-17 proteins in chromatin is independent of DNA sequence. J Biol Chem 2000, 275:37937–37944.PubMedCrossRef 14. Catez F, Lim JH, Hock R, Postnikov YV, Bustin M: HMGN dynamics and chromatin function. Biochem Cell Biol 2003, 81:113–122.PubMedCrossRef 15. Rochman M, Postnikov Y, Correll S, Malicet C, Wincovitch S, Karpova TS, McNally JG, Wu X, Bubunenko NA, Grigoryev S, Bustin M: The interaction of NSBP1/HMGN5 with nucleosomes in euchromatin counteracts linker
histone-mediated chromatin compaction and modulates transcription, Mol. Cell 2009, 35:642–656. 16. Rattner BP, Yusufzai T, Kadonaga JT: HMGN proteins act in opposition
to ATP-dependent chromatin remodeling factors to find more restrict nucleosome mobility. Mol Cell 2009, 34:620–626.PubMedCrossRef Go6983 solubility dmso 17. Rozenblat S, Grossman S, Bergman www.selleckchem.com/products/ABT-737.html M, Gottlieb H, Cohen Y, Dovrat S: Induction of G2/M arrest and apoptosis by sesquiterpene lactones in human melanoma cell lines. Biochem Pharmacol 2008, 75:369–382.PubMedCrossRef 18. Beauman SR, Campos B, Kaetzel MA, Dedmana JR: CyclinB1 expression is elevated and mitosis is delayed in HeLa cells expressing autonomous CaMKII. Cell Signal 2003, 15:1049–1057.PubMedCrossRef 19. Chulu JuliusLC, Huang Wei R, Wang L, Shih Wen L, Liu Hung J: Avian Reovirus Nonstructural Protein p17-Induced G2/M Cell Cycle Arrest and Host Cellular Protein Translation Shutoff Involve Activation of p53-Dependent Pathways. J Virol 2010, 84:7683–7694.PubMedCrossRef 20. Yin J, Chen G, Liu Y, Liu S, Wang P, Wan Y, Wang X, Zhu J, Gao H: Downregulation of SPARC expression decreases gastric cancer cellular invasion and survival. J Exp Clin Cancer Res 2010, 29:59.PubMedCrossRef 21. Rink M, Chun FK, Robinson B, Sun M, Karakiewicz 3-oxoacyl-(acyl-carrier-protein) reductase PI, Bensalah K, Fisch M, Scherr DS, Lee RK, Margulis V, Shariat SF: Tissue-based molecular markers for renal cell carcinoma. Minerva Urol Nefrol 2011, 63:293–308.PubMed 22. Chang HR, Chen PN, Yang SF, Sun YS, Wu SW, Hung TW, Lian JD, Chu SC, Hsieh YS: Silibinin inhibits the invasion and migration of renal carcinoma 786-O cells in vitro, inhibits the growth
of xenografts in vivo and enhances chemosensitivity to 5-fluorouracil and paclitaxel. Mol Carcinog 2011, 50:811–823.PubMedCrossRef Competing interests The authors declare that they have no competing interests. Authors’ contributions SQJ supervised research project, participated in the data collection, drafted the manuscript. LY participated in the data collection, supervised ICH. XYZ participated in the data collection. XSL carried out the operation. LQZ carried out the operation, acted as corresponding author and did the revisions. All authors read and approved the final manuscript.”
“Retraction The authors would like to retract the article “”Screening and Identification of a Renal Carcinoma Specific Peptide from a Phage Display Peptide Library”" [1].